SARS-CoV-2 :Ab Independently Validated
GeneTex has partnered with HistoWiz Inc., to establish three highly validated antibodies for immunohistochemistry (IHC) based on results using human SARS-CoV-2-infected tissues. These include the published mouse monoclonal [1A9] clone (GTX632604) against SARS-CoV/SARS-CoV-2 spike protein and two new recombinant rabbit monoclonal antibodies targeting SARS-CoV-2 nucleocapsid protein (clones [HL344] (GTX635679) and [HL448] (GTX635686)), with GTX635686 demonstrating unprecedented sensitivity for IHC.
Genetex collaboration with HistoWiz Inc. has established the groundwork for the development and IHC optimization of additional antibodies for this important application.
GeneTex continua a espandere il portfolio di prodotti per SARS-CoV-2. Scopri l'offerta completa a questo link: